Stockreport

How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF fair value estimate and a US$14 target reiterated rather than reset. Supportive views lean on what bullish analysts describe as "robust" preliminary Q3 sales and improvi [Read more]